Table 4.
Outcome of DTC with respect to BRAFV600E, TERT promoter mutations or both.
Total No. (%) |
NED No. (%) |
PD No. (%) |
P value | |
---|---|---|---|---|
BRAFV600E mutation | 137 (46.3) | 74/175 (42.3) | 63/121 (52.1) | 0.12 |
TERT promoter mutations | 72 (24.3) | 27/175 (15.4) | 45/121 (37.2) | <0.0001 |
BRAFV600E+TERT promoter mutations | 34 (11.5) | 8/175 (4.9) | 26/121 (21.5) | <0.0001 |
NED, no evidence of disease; PD, persistent disease.